Literature DB >> 15762291

Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis.

Ellen Butensky1, Roland Fischer, Mark Hudes, Laurie Schumacher, Roger Williams, Thomas P Moyer, Elliott Vichinsky, Paul Harmatz.   

Abstract

In patients with sickle cell disease or beta-thalassemia receiving RBC transfusions for a long period, a precise knowledge of the liver iron concentration (LIC) is essential for treatment. Patients underwent LIC and liver pathology assessment by duplicate biopsies in 2 passes from the same local liver site. Fresh tissue cores in trace element-free containers and tissues from dissolved paraffin-embedded cores were analyzed. LIC measurements in each of 2 paraffin-embedded cores did not differ significantly (median, 12,455 vs 12,153 microg/g dry weight; n = 29). A significant difference was observed when 1 fresh tissue sample and 1 paraffin-embedded core were analyzed (median, 11,716 vs 12,864 microg/g dry weight; n = 16; P < .001) with a median disagreement between LIC measurements of 23.0%. We found high agreement in LICs between liver biopsy specimens processed by the paraffin-embedding technique but overestimation of LICs in comparison with desiccated fresh tissue samples.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15762291     DOI: 10.1309/puuxegxdlh26nxa2

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  18 in total

1.  Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin.

Authors:  Bryan D Maliken; William F Avrin; James E Nelson; Jody Mooney; Sankaran Kumar; Kris V Kowdley
Journal:  Ann Hepatol       Date:  2012 Jan-Feb       Impact factor: 2.400

Review 2.  Magnetic resonance imaging measurement of iron overload.

Authors:  John C Wood
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

Review 3.  Use of magnetic resonance imaging to monitor iron overload.

Authors:  John C Wood
Journal:  Hematol Oncol Clin North Am       Date:  2014-08       Impact factor: 3.722

4.  Simultaneous field and R2 mapping to quantify liver iron content using autoregressive moving average modeling.

Authors:  Brian A Taylor; Ralf B Loeffler; Ruitian Song; M Beth McCarville; Jane S Hankins; Claudia M Hillenbrand
Journal:  J Magn Reson Imaging       Date:  2011-12-16       Impact factor: 4.813

5.  Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration.

Authors:  Jianqi Li; Huimin Lin; Tian Liu; Zhuwei Zhang; Martin R Prince; Kelly Gillen; Xu Yan; Qi Song; Ting Hua; Xiance Zhao; Miao Zhang; Yu Zhao; Gaiying Li; Guangyu Tang; Guang Yang; Gary M Brittenham; Yi Wang
Journal:  J Magn Reson Imaging       Date:  2018-03-22       Impact factor: 4.813

Review 6.  Optimal management strategies for chronic iron overload.

Authors:  James C Barton
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 7.  Estimating tissue iron burden: current status and future prospects.

Authors:  John C Wood
Journal:  Br J Haematol       Date:  2015-03-12       Impact factor: 6.998

8.  Effect of deferasirox chelation on liver iron and total body iron concentration.

Authors:  Javed Ahmed; Noor Ahmad; Bhavin Jankharia; Pradeep Krishnan; Rashid H Merchant
Journal:  Indian J Pediatr       Date:  2013-05-29       Impact factor: 1.967

9.  Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease.

Authors:  Nilesh R Ghugre; Ignacio Gonzalez-Gomez; Ellen Butensky; Leila Noetzli; Roland Fischer; Roger Williams; Paul Harmatz; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2009-08       Impact factor: 10.047

10.  Comparison between different software programs and post-processing techniques for the MRI quantification of liver iron concentration in thalassemia patients.

Authors:  Lorenzo Bacigalupo; Francesco Paparo; Daniele Zefiro; Carlo Maria Viberti; Luca Cevasco; Barbara Gianesin; Valeria Maria Pinto; Gian Andrea Rollandi; John C Wood; Gian Luca Forni
Journal:  Radiol Med       Date:  2016-06-22       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.